Bausch & Lomb (FRA:S2L) YoY Rev. per Sh. Growth : 15.94% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Bausch & Lomb's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 was 15.94%.

Bausch & Lomb's Revenue per Share for the three months ended in Mar. 2024 was €2.88.

Bausch & Lomb YoY Rev. per Sh. Growth Historical Data

The historical data trend for Bausch & Lomb's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb YoY Rev. per Sh. Growth Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

5.55

-17.52

18.81

6.69

6.79

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial												7.72	7.31	-1.03	14.28	15.94

Bausch & Lomb YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Bausch & Lomb's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(10.847	-	10.157)	/	\| 10.157 \|
=	6.79 %

Bausch & Lomb's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Mar. 2024 )
=	(Revenue per Share (Q: Mar. 2024 )	-	Revenue per Share (Q: Mar. 2023 ))	/	\| Revenue per Share (Q: Mar. 2023 )) \|
=	(2.88	-	2.484)	/	\| 2.484 \|
=	15.94 %

Bausch & Lomb YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb (FRA:S2L) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (FRA:S2L) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

BLCO:USA BLCO:Canada

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Bausch & Lomb (FRA:S2L) Headlines

No Headlines